SOURCES:
Barbara Giesser, MD, neurologist, MS specialist, Pacific Neuroscience Institute at Windfall Saint John’s Well being Middle, Santa Monica, CA.
Gabriel Pardo, MD, director, Oklahoma Medical Analysis Basis’s A number of Sclerosis Middle of Excellence, Oklahoma Metropolis.
Nationwide A number of Sclerosis Society: “Adherence.”
A number of Sclerosis Belief (U.Ok.): “When Can You Safely Cease Taking Illness Modifying Medicine?”
Journal of Neurology, Neurosurgery, and Psychiatry: “Discontinuing disease-modifying remedy in MS after a protracted relapse-free interval: a propensity score-matched research.”
Worldwide Journal of MS Care: “Stopping Illness-Modifying Remedy in Nonrelapsing A number of Sclerosis.
Affected person-Centered Outcomes Analysis Institute: “Can Some MS Sufferers Safely Cease Taking Medicines?”
